BASEL, Switzerland, Jan. 03, 2024 (GLOBE NEWSWIRE) Noema Pharma, a clinical-stage biotech company targeting debilitating central nervous system (CNS) disorders, today announced that members of management will attend and present at two upcoming conferences in San Francisco, CA. SACHS 7th Annual Neuroscience Innovation ForumFormat: Panel DiscussionTitle: Exploring New Modalities for Rare & Orphan Neurological DiseasesDate: Sunday, January 7, 2024 Time: 11:00 a.m. PST (2:00 p.m. EST/8:00 p.m. CE
Noema Pharma Appoints Robert Lasser, M D , as Chief Medical Officer tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.
Sofinnova Partners created and seed financed Noema in 2019 to advance clinical assets in-licensed from Roche This milestone underscores Sofinnova's ability to form, build and grow companies around